Drug Discovery

Loading the player...

Results: ORION-9 with Frederick Raal, PhD

Derick Raal, PhD, principal Investigator of the ORION-9 trial provides a brief overview of the results and their significance for patients with familial hypercholesterolemia. Dr. Raal is on the faculty of Health Sciences at the University of the Witwatersrand in Johannesburg, South Africa. See this study and other late-breaking science presentations on our AHA Science News page.

Science NewsView All Science News

HYPERTENSION | Trending Topics | January 2020
01/24/2020 | Hypertension Trending Topics for January 2020
CIRCULATION RESEARCH | Featured Articles | January 2020
01/21/2020 | CIRCULATION RESEARCH Featured articles for January 2020
ATVB | Featured Articles | January 2020
01/17/2020 | ATVB January 2020 Editor's Pick and Featured Article
Science News 2019 Scientific Sessions
11/16/2019 | Science News coverage of selected presentations and interviews from AHA's Scientific Sessions 2019. Nov. 16-18, 2019 in Philadelphia, PA.

Related Councils

Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)

Mary Sorci-Thomas, PhD, FAHA

The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.

Mary Sorci-Thomas, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology

Vascular Discovery Scientific Sessions       Arteriosclerosis, Thrombosis, and Vascular Biology       ATVB Council Awards

Council on Clinical Cardiology (CLCD)

Eldrin Lewis, MD, MPH, FAHA, FACC

The purpose of the Council on Clinical Cardiology (CLCD) is to achieve the objectives of the American Heart Association (AHA) in the field of clinical cardiology, to promote excellence in clinical care and to foster the professional development and education of clinical cardiologists. Through council-sponsored symposia, panels and scientific conferences, members can access new developments in the field and interpret and promote clinical cardiology to professional and lay audiences.

Eldrin Lewis, MD, MPH, FAHA, FACC
Chair, Council on Clinical Cardiology

Scientific Sessions       Circulation       CLCD Council Awards

Council on Genomic and Precision Medicine (GPM)

Thomas J. Wang, MD, FAHA

The mission of the American Heart Association Council on Genomic and Precision Medicine (GPM) is to advance the discovery and translation of biological insights gained from genetics and omics technologies to improve cardiovascular and brain health. Our constituency’s expertise spans across genetics, genomics, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, population health, clinical genetics and genomic medicine, with the ultimate goal of more precise risk prediction, treatment and prevention for patients and the population. Integral to the American Heart Association’s goals, the GPM Council provides a premier inter-disciplinary forum promoting and integrating new knowledge from molecules to populations in translational cardiovascular science and precision medicine.

Thomas J. Wang, MD, FAHA
Chair, Council on Genomic and Precision Medicine

Scientific Sessions       Circulation: Genomic and Precision Medicine      GPM Council Awards